ReviewFrontiers in immunology2026
The role and mechanisms of multiple immunoregulatory cells in pulmonary tuberculosis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The eight pillars of within-host tuberculosis modelling.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary tuberculosis (PTB) is a complex respiratory illness and a leading cause of mortality from infectious diseases globally. The regulation of the host immune response is integral to the chronic infection process of PTB. In this process, the excessive activation of the host's negative immune regulatory mechanisms serves as the core pathological basis driving infection chronicity and facilitating pathogen immune evasion. Many reviews highlight successful therapeutic approaches aimed at regulatory immune cells. Understanding the roles of various regulatory immune cells in PTB is of paramount importance. This paper examines key regulatory immune cells involved in the PTB infection process, such as regulatory T cells (Tregs), regulatory B cells (Bregs), myeloid-derived suppressor cells (MDSCs), and macrophages. Furthermore, the study delves into the mechanisms by which regulatory immune cells induce immunosuppressive functions. In summary, gaining a deep understanding of the immunosuppressive network in PTB will provide a theoretical basis for developing more effective new immunotherapy regimens.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.